| 000 | 01617 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513103708.0 | ||
| 264 | 0 | _c19961203 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMyers, R B | |
| 245 | 0 | 0 |
_aElevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cOct 1996 |
||
| 300 |
_a398-402 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _ximmunology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNF-kappa B _xblood |
| 650 | 0 | 4 | _aNF-kappa B p50 Subunit |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xanalysis |
| 650 | 0 | 4 |
_aProstatic Diseases _ximmunology |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _ximmunology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aProtein Precursors _xblood |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xblood |
| 700 | 1 | _aBrown, D | |
| 700 | 1 | _aOelschlager, D K | |
| 700 | 1 | _aWaterbor, J W | |
| 700 | 1 | _aMarshall, M E | |
| 700 | 1 | _aSrivastava, S | |
| 700 | 1 | _aStockard, C R | |
| 700 | 1 | _aUrban, D A | |
| 700 | 1 | _aGrizzle, W E | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 69 _gno. 5 _gp. 398-402 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0215(19961021)69:5<398::AID-IJC8>3.0.CO;2-0 _zAvailable from publisher's website |
| 999 |
_c8892934 _d8892934 |
||